Nanoveu Limited Overview
Nanoveu began as a nanotechnology films company. Its products were EyeFly3D glasses-free 3D screen films and Nanoshield copper-ion antimicrobial films. It is now a fabless edge-AI semiconductor developer, and its consumer-optics and coatings businesses are secondary. The change came with the March 2025 acquisition of Embedded A.I. Systems Pte Ltd (EMASS), which was paid for entirely in shares. EMASS is a spinout from Singapore's Nanyang Technological University. Its ECS-DoT system-on-chip runs AI inference at sub-milliwatt power. The company currently offers the chip at 22nm and received first 16nm engineering samples from TSMC in September 2026. In July 2026 Nanoveu bought Spinoff Robotics, a spinout of the Singapore University of Technology and Design. This gave it in-house drone airframes, and the company now describes its offer as a full "silicon-to-airframe" drone stack. Commercial traction is still minimal: FY2025 revenue was A$0.30M and H1 FY2026 revenue was A$0.007M. The company depends on equity raisings. Investors are therefore valuing technology optionality on a roughly A$60M market capitalisation rather than any earnings base.
Company's own description (FY2025 Annual Report, paraphrased)
The company describes its principal activity as developing and commercialising advanced technologies in three fields: semiconductor systems, visualisation software and materials science. It runs these through three operating divisions:
EMASS (Semiconductor Technology): EMASS designs systems-on-chip (SoCs) for ultra-low-power, AI-driven processing. Target uses are smart devices, IoT and 3D content transformation, sold into edge-computing markets.
EyeFly3D™ (Nanotechnology and Software): This is a proprietary display enhancement that gives glasses-free 3D on mobile and consumer displays. It combines nanostructured optical films with AI-driven 2D-to-3D software and targets mobile content, entertainment, e-commerce and gaming.
Nanoshield™ (Materials Science and Coatings): This is a protective coating for photovoltaic panels and, in the H1 FY2026 description, also concentrated solar power (CSP). It is meant to reduce biofilm, algae and environmental degradation.
Since July 2026, a Drone Division built from Spinoff Robotics sits alongside EMASS. Its job is to commercialise ECS-DoT in unmanned aerial systems.
Business model and revenue model
| Revenue stream | Segment | Model | Status (as of Oct 2026) |
|---|---|---|---|
| ECS-DoT chip sales (22nm, later 16nm) | Semiconductor | Product sales through OEM design-ins and distributors (Arrow collaboration; a China distributor appointed in Q2 2026) | No semiconductor revenue recognised in FY2025 or H1 FY2026 |
| Evaluation boards, reference designs, SDKs | Semiconductor | Product sales and design-in enablement | No disclosed revenue |
| Licensing and engineering services | Semiconductor | IP licensing and non-recurring engineering (NRE), per the segment definition | No disclosed revenue |
| Drone platforms (ALICE tethered drone, METRON photogrammetry) | Drone (within Semiconductor/new) | Hardware sales plus ECS-DoT-enabled solutions to drone OEMs | Acquired July 2026; no revenue disclosed |
| EyeFly3D films (screen protectors) | EyeFly3D | Hardware sales through OEMs and distributors, via the 51%-owned Fullveu JV | A$285,164 in FY2025; A$6,954 in H1 FY2026; US$300K India pilot purchase order (Aug 2026) |
| EyeFly3D software / white-label SaaS | EyeFly3D | Planned subscription and licensing model | Strategic intent only |
| Nanoshield coatings / licences | Nanoshield | Product sales; exclusive CSP licence with Diamon-Fusion International | A$12,418 in FY2025; nil in H1 FY2026 |
Revenue mix (FY2025, audited): all revenue was recorded as "sale of goods" (A$297,582). EyeFly3D supplied 95.8% and Nanoshield 4.2%. There was no subscription, licensing or service revenue.
Value-chain position
EMASS is a fabless chip designer. It owns the architecture (RISC-V core, deep-learning accelerators and the power-management fabric), the IP, the software toolchain and the reference designs. Wafer fabrication is outsourced to TSMC. Packaging, test and distribution are handled by third parties, with Arrow Electronics collaborating on boards and developer tools. With Spinoff Robotics, Nanoveu now also does system-level airframe and flight-control engineering. The company calls the result a "silicon-to-airframe" or "Atoms-to-Apps" stack. EyeFly3D buys films through its Hong Kong JV with Shenzhen Fullsand Printing & Packaging. Under the JV agreements, product is supplied at an 8% premium to manufacturing cost.
Customer types and end-markets
Semiconductor: OEMs and integrators in consumer wearables, hearables and hearing aids, smart glasses, smart home and security, asset tracking and logistics, industrial monitoring and predictive maintenance, and drones/robotics including defence (H1 FY2026 Interim Report).
EyeFly3D: B2B partners with content (OTT platforms, distributors). Examples are One Immersive Inc. in India and Rahum Nano Tech in South Korea.
Nanoshield: solar farm and CSP operators and industrial PV owners. Ageing panels (3–5 years old) are the stated initial target because OEM warranties restrict coatings on new panels.
Independent characterisation
Nanoveu is a pre-revenue deep-tech holding company, listed on the ASX microcap board and funded by equity. Its economic value sits almost entirely in the EMASS intangible, carried at A$10.49M. That figure is the share-based acquisition cost, not an independent valuation. The legacy divisions have produced small, irregular revenue for eight years. They now serve mainly as a source of near-term cash and as secondary applications for EMASS: EMASS's Class A performance rights are tied to running the 2D-to-3D model on ECS-DoT. The investment case rests on three questions. Will ECS-DoT win production design-ins? Will that happen before the company needs much more dilutive capital? And can a roughly 1.09bn-share, 1.49bn fully diluted company produce per-share value from a chip startup's economics?
Strategy
Stated strategy (FY2025 Annual Report, paraphrased themes)
Commercialise, expand markets, integrate technology: The focus is building commercial partnerships that embed EMASS technology into real-world edge-AI products and drive industry adoption.
EyeFly3D: grow hardware sales while developing a white-labelled B2B SaaS platform that enables subscription and licensing revenue.
Nanoshield Solar: grow sales and expand markets on the back of field trials.
Overall aim: scale the commercial footprint, strengthen alliances and achieve sustained revenue growth.
Semiconductor near-term priorities: validate production silicon, continue OEM engagement, and progress to early commercial design-ins.
Strategic initiatives (last 24 months)
| Initiative | Date | Description | Status |
|---|---|---|---|
| Pivot to semiconductors (EMASS) | Oct 2024–Mar 2025 | Acquired an NTU-origin fabless edge-AI SoC company | Completed |
| Semiconductor leadership build-out | Jan–Apr 2025 | Goranson appointed CEO; US team expanded | Completed |
| Two-node silicon roadmap | 2025–2026 | 22nm commercial; 16nm taped out in Jan 2026 with samples in Sep 2026; smaller nodes under evaluation | Characterisation under way |
| 22nm full-mask tape-out | H2 2026 (expected) | Move from earlier manufacturing runs to a production mask set | Pending |
| Drone vertical | Oct 2025–Jul 2026 | Simulations, live trials, NTU swarm IP licence, Spinoff Robotics acquisition | Executing |
| Ecosystem partnerships | 2025–2026 | Arrow, Semtech, Bosch Sensortec, STMicro sensing (reference design), Weebit Nano (ReRAM) | Ongoing |
| Channel build | 2025–2026 | US sales and representation network; China distributor (Q2 2026) | Ongoing |
| EyeFly3D B2B refocus | 2024–2026 | Fullveu JV, Korea and India OEM deals, content-partner model | Pilot stage |
| Nanoshield CSP | H1 2026 | Exclusive Diamon-Fusion CSP licence | Early stage |
| Capital programme | Jan 2026 | A$7.5M placement at A$0.088 with 1-for-2 options at A$0.15 | Completed |
| US investor access | 2024–2025 | OTCQB quotation (NNVUF) | Completed |
ESG / sustainability commitments
No formal emissions targets or ESG programmes are disclosed. The Annual Report states the company is not subject to significant environmental regulation.
Cost programmes
No formal cost-reduction targets are disclosed. The Malaysian entity was dissolved.
Medium-term financial targets / guidance
Not publicly disclosed. The company gives no revenue or earnings guidance. The incentive structures do signal management's own milestones:
-
EMASS Class C performance rights vest on A$1M of cumulative contracted revenue over 12 months, with an expiry of 18 Mar 2030.
-
Fullveu-linked performance rights target US$2.5M of Fullveu revenue for FY2026 (tranche B, 6M rights) and a further 10M rights expiring 31 Dec 2027.
-
Market-based rights vest at 20-day VWAPs of A$0.10, A$0.15 and A$0.20.
-
A legacy hurdle of A$15M consolidated revenue for FY2025 (tranche C) was missed and lapsed.
Products & Services
Semiconductor (EMASS)
| Product | Description and key capabilities | Target customer | Launch / version | Pricing |
|---|---|---|---|---|
| ECS-DoT 22nm SoC | Fabless edge-AI SoC with a RISC-V core, dual deep-learning accelerators, scalable compute-to-memory interconnect and an always-on design. Real-time inference at sub-mW to low-mW power. Demonstrated running keyword detection and voice recognition at the same time at about 400–500 µW average power with roughly 4ms latency (Jun 2026). | Wearables, hearables, smart home, asset tracking, industrial IoT, drones | Commercially available; full-mask 22nm tape-out expected to start in H2 2026 | — |
| ECS-DoT 16nm SoC | TSMC 16nm FinFET. Keeps the 22nm architecture and adds an integrated Bluetooth Low Energy radio subsystem, expanded on-chip SRAM, a dedicated object-detection accelerator (non-maximum suppression stage covered by exclusively licensed US Patent 12,651,452 B2), a hardware FP16/FP32 floating-point unit, and a fine-grained adaptive power-management fabric without DVFS. Software and toolchain compatible with the 22nm chip. | Customers needing vision plus audio plus sensor fusion with integrated wireless | GDS sign-off Dec 2025; tape-out Jan 2026; engineering samples received ~Sep 2026; characterisation under way | — |
| Evaluation boards and compact AI prototyping board | Development hardware for ECS-DoT. A compact board was unveiled in 2024–25. | OEM engineers | 2024–2026 | — |
| SDK / AI toolchain | Model compression and deployment tools ("Atoms-to-Apps" method) | OEM developers | Ongoing | — |
| Reference design: hearables keyword spotting | Always-on bone-conduction keyword spotting combining STMicroelectronics inertial sensing with ECS-DoT. Microphone-free keyword spotting below 1mW. | Hearables and hearing aids | Mar 2026; Jun 2026 | — |
| Reference design: asset tracking (with Bosch Sensortec) | Five Bosch MEMS sensors (motion, environmental, pressure, magnetic, gas) with ECS-DoT for context-aware tracking, including GPS-denied environments | Logistics, cold chain, industrial IoT | Jul 2026 | — |
| Reference design: LoRa intelligent sensing (with Semtech) | ECS-DoT combined with Semtech LoRa transceivers for long-range, battery-efficient predictive maintenance and acoustic event detection | Industrial IoT | Q4 2025 | — |
| ECS-DoT drone flight-control AI | Closed-loop AI flight optimisation. Simulation showed about 60% average and up to 85% peak endurance gains. Live trials: 27.2% average cruise-efficiency gain (Jun 2026) and 48.5% average at 7 m/s (Jul 2026, Phase 2), using under 10mW total system power, with no battery or airframe changes. | Drone OEMs, defence, inspection | Live trials 2026 | — |
| Fall-detection demo | Ultra-low-power fall detection on ECS chip | Health wearables | 2024–25 | — |
Drone Division (Spinoff Robotics, acquired July 2026)
| Product | Description | Target customer | Status |
|---|---|---|---|
| ALICE | Proprietary tethered drone platform for persistent station-keeping, such as surveillance and monitoring | Defence, security, infrastructure | Company describes it as in active commercial deployment; no revenue disclosed |
| METRON | Drone platform for sub-millimetre photogrammetry | Infrastructure inspection | Commercially validated per company; no revenue disclosed |
| Planned capabilities | GPS-free navigation, counter-drone detection, AI flight optimisation (using the NTU swarm IP licence) | Drone OEMs, defence | Development roadmap |
EyeFly3D
| Product | Description | Target customer | Status / pricing |
|---|---|---|---|
| EyeFly3D films | Plastic (PET) or tempered-glass screen protectors engineered with around half a million nano-lenses for glasses-free 3D. The 3D effect has been toned down to address eye-strain complaints. | Smartphone users via OEMs and distributors | Korea (Rahum, 2024); India (One Immersive pilot purchase order of US$300K, Aug 2026). Price n.d. |
| EyeFly3D AI 2D-to-3D software / app | Monocular depth estimation converts 2D content to 3D in real time | OTT and content partners | Planned white-label B2B SaaS and licensing |
| EyeFyx (legacy, development) | Vision-correction display concept using hardware and software | Consumers | Legacy development; current status not disclosed |
Nanoshield
| Product | Description | Status |
|---|---|---|
| Nanoshield Solar | Anti-fouling, anti-biofilm coating for PV panels; field trials in hot, arid regions (EMEA referenced) | Trials; FY2025 revenue A$12.4K |
| Nanoshield CSP (Diamon-Fusion licence) | Exclusive global licence to use Diamon-Fusion® nanocoating in concentrated solar power | Signed in H1 FY2026; aims to improve asset performance and reduce water and maintenance |
| Nanoshield antiviral / antimicrobial films | Copper-ion film for screens, cases and commercial surfaces | Legacy COVID-era product |
| Nanoshield Marine | Anti-biofouling for submerged surfaces | Legacy; status not disclosed |
| Customskins (legacy) | Vending machines that apply screen covers | Legacy; status not disclosed |
Financial Narrative
Income statement — 5-year summary
Sources: FY2024–FY2025 revenue is from the audited FY2025 Annual Report. Net loss and EPS for all years are from the FY2025 Remuneration Report's five-year table. Diluted EPS equals basic EPS because options are anti-dilutive.
Revenue CAGR FY2021–FY2025 (calculated): -21.4% a year. The pattern is volatile rather than a steady decline: revenue peaked in the COVID-era Nanoshield period, was near zero in FY2024, and partly recovered in FY2025 on EyeFly3D JV shipments.
Income statement — detailed (audited)
Notes: FY2024 cost of sales was a credit of A$3.7K, which produced a gross profit above revenue. This is an accounting anomaly. EBITDA is calculated as operating loss plus D&A from Note 6 (A$173.1K). The cash-flow reconciliation shows only A$32.6K of non-cash D&A, which is an internal inconsistency in the filing. FY2025 administration expense includes a one-off A$692.6K donation to a university to support research collaboration, A$755.2K of consulting fees, and A$1.63M of director and employee costs.
Margins (calculated from audited figures)
Margins are not economically meaningful at this revenue level. The FY2025 negative gross margin (cost of sales of A$929.7K on revenue of A$297.6K) suggests inventory write-downs, under-absorbed production cost or below-cost pilot pricing at EyeFly3D. The filing does not break this out.
Balance sheet
Notes: FY2024 cash of A$498.3K included A$400K of restricted cash. The FY2025 going-concern note states net current assets of A$1,284,566. That differs from the A$1,356,457 calculated from the balance sheet, a discrepancy within the filing. FY2023 closing total equity was -A$109.4K (from the statement of changes in equity). Other FY2021–FY2023 balance-sheet lines are not publicly disclosed in the sources reviewed.
Latest balance sheet (30 Jun 2026, reviewed): total assets A$17.66M; cash A$5.14M; intangibles A$10.50M; loan receivable A$451.8K; contract liabilities A$544.4K; interest-free loan A$237.7K; lease liabilities A$477.6K; total equity A$15.52M (owners A$15.87M, NCI -A$0.35M); working capital A$4.68M.
Cash flow
H1 FY2026 (reviewed): operating cash flow -A$3.93M (H1 FY2025: -A$1.99M); capex -A$13K; net financing +A$7.28M, of which the placement was A$7.03M and option exercises A$0.19M. Customer receipts were A$392K, much higher than recognised revenue of A$7K. This reflects deposits, including about US$165K from One Immersive, held as contract liabilities.
Ratios (calculated)
ROIC, net debt/EBITDA, interest coverage and cash conversion cycle are not meaningful. Operating earnings are negative, the company holds net cash, finance costs are trivial (A$13.7K) and there is no material inventory or receivables cycle. FY2024 ROE and ROA cannot be meaningfully calculated because the average FY2023–FY2024 equity base was about A$0.11M, and FY2023 total assets are not disclosed.
Commentary — trends, inflections and drivers
-
The FY2025 inflection is in costs, not revenue. Operating cash burn more than tripled, from A$1.84M to A$5.85M. In H1 FY2026 the run-rate reached about A$7.9M a year (A$3.93M per half). This is the cost of running an international chip design team across Singapore, Cairo and the US, a TSMC tape-out and drone programs.
-
The balance sheet was rebuilt with equity. Equity went from A$0.34M to A$12.09M in FY2025, almost entirely from the share-funded EMASS acquisition (A$10.47M) and A$7.47M of net cash raised. The A$10.5M intangible is "not yet available for use". It is therefore not amortised and is tested for impairment each year, using fair value less costs of disposal based on the original arm's-length deal price.
-
Funding is short. Cash of A$5.14M at 30 June 2026, at the H1 burn rate of about A$0.66M a month, gives roughly 7–8 months of runway to around Q1 2027 before new inflows. Possible inflows: the A$433.5K India purchase order balance; in-the-money options (93.4M unlisted at A$0.05 expiring 31 Dec 2026, about A$4.7M if exercised; 68.8M listed at A$0.045 expiring May 2027, about A$3.1M); and repayment of the Hongtai Sheng loan, which matured 31 July 2026 (A$452K at book). The directors' going-concern conclusion relies on existing cash plus forecast product receipts.
-
Share-based payment intensity is high. Share-based payments were A$1.42M in FY2025, equal to 4.8 times revenue. Director share-based payments made up 59% of key management remuneration.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment revenue (AUD K)
| Segment revenue (AUD K) | FY2024 | FY2025 |
|---|---|---|
Semiconductor | 0 | 0 |
EyeFly 3D | 6.9 | 285.2 |
Nanoshield | 0 | 12.4 |
Corporate | 0 | 0 |
Total | 6.9 | 297.6 |
Segment profit or loss (AUD K)
| Segment profit or loss (AUD K) | FY2024 | FY2025 |
|---|---|---|
Semiconductor | 0 | -2,501.0 |
EyeFly 3D | -1,039.6 | -1,149.3 |
Nanoshield | -12.0 | -104.6 |
Corporate | -1,794.8 | -3,847.3 |
Total | -2,846.4 | -7,601.2 |
Segment Overview
| Segment | Revenue share (%) | YoY revenue growth | Segment margin (loss/revenue) |
|---|---|---|---|
Semiconductor | 0.0 | — | n.m. (no revenue) |
EyeFly 3D | 95.8 | +4,049% | -403% |
Nanoshield | 4.2 | n.m. (nil base) | -843% |
Corporate | 0.0 | — | — |
Revenue by Segment
| Segment (AUD K) | H1 FY2025 revenue | H1 FY2026 revenue | H1 FY2025 profit/(loss) | H1 FY2026 profit/(loss) |
|---|---|---|---|---|
Semiconductor | 0 | 0 | -347.3 | -2,183.6 |
EyeFly 3D | 268.7 | 7.0 | -265.6 | -980.9 |
Nanoshield | 12.4 | 0 | -117.5 | -53.6 |
Corporate | 0 | 0 | -2,307.2 | -1,076.7 |
Total | 281.1 | 7.0 | -3,037.6 | -4,294.8 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansGroup Entities
| Entity | Jurisdiction | Ownership | Role |
|---|---|---|---|
Nanoveu Limited | Australia | Parent | Listed holding company |
Nanoveu Pte Ltd | Singapore | 100% | Original operating company (EyeFly3D, Nanoshield) |
Fullveu Technologies (HK) Ltd | Hong Kong | 51% (Fullsand 49%) | EyeFly3D commercial JV |
Nanoveu EMASS Pty Ltd | Australia | 100% | Holding vehicle for EMASS |
Embedded A.I. Systems Pte Ltd | Singapore | 100% | Semiconductor design and IP |
Embedded A.I. Systems Inc | USA | 100% | US sales and engineering |
Spinoff Robotics Pte Ltd | Singapore | 100% (from 2 Jul 2026) | Drone Division |
Nanoveu Sdn Bhd | Malaysia | Dissolved in H1 FY2026 | Formerly dormant |
Income Statement and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (AUD K) | 781.2 | 159.5 | 102.5 | 6.9 | 297.6 |
Net loss (AUD K) | -2,320.6 | -2,707.3 | -2,159.9 | -2,846.4 | -7,601.2 |
Basic EPS (AUD cents) | -1.2 | -1.2 | -0.6 | -0.6 | -0.9 |
Diluted EPS (AUD cents) | -1.2 | -1.2 | -0.6 | -0.6 | -0.9 |
Dividends per share (AUD cents) | 0 | 0 | 0 | 0 | 0 |
Income Statement
| Metric (AUD K) | FY2024 | FY2025 |
|---|---|---|
Revenue | 6.9 | 297.6 |
Cost of sales | 3.7 | -929.7 |
Gross profit | 10.5 | -632.1 |
Other operating income | 21.5 | 6.4 |
Selling and distribution | -26.3 | -386.9 |
Administration | -2,133.3 | -4,424.9 |
Research costs | -53.2 | -760.8 |
Share-based payments | -667.0 | -1,421.9 |
Operating loss | -2,847.7 | -7,620.3 |
Depreciation and amortisation | 107.5 | 173.1 |
EBITDA (calculated) | -2,740.2 | -7,447.2 |
Finance income | 7.1 | 32.8 |
Finance costs | -5.7 | -13.7 |
Pre-tax loss | -2,846.4 | -7,601.2 |
Net loss | -2,846.4 | -7,601.2 |
Net loss attributable to owners | -2,809.7 | -7,423.3 |
Margin (%)
| Margin (%) | FY2024 | FY2025 |
|---|---|---|
Gross margin | 153.2 | -212.4 |
Operating margin | -41,433 | -2,560.7 |
EBITDA margin | -39,869 | -2,502.6 |
Net margin | -41,414 | -2,554.3 |
Income Statement and Per-Share Data (Half-Yearly)
| Metric (AUD K) | H1 FY2025 | H1 FY2026 |
|---|---|---|
Revenue | 281.1 | 7.0 |
Gross profit | 177.0 | 7.0 |
Administration | -1,635.8 | -3,042.9 |
Research costs | -138.1 | -421.4 |
Share-based payments | -1,332.1 | -482.0 |
Impairment | 0 | -41.7 |
Operating loss | -3,036.2 | -4,336.2 |
Net loss (total) | -3,037.6 | -4,294.8 |
Net loss attributable to owners | -2,968.8 | -4,158.4 |
Basic EPS (AUD cents) | -0.44 | -0.40 |
Balance Sheet
| Metric (AUD K) | FY2024 | FY2025 |
|---|---|---|
Total assets | 1,321.9 | 13,554.9 |
Cash and equivalents | 498.3 | 1,807.7 |
Short-term debt (interest-free loan plus current lease) | 126.3 | 198.2 |
Long-term debt (non-current lease) | 0 | 71.9 |
Total debt incl. leases | 126.3 | 270.1 |
Net debt (negative = net cash) | -372.0 | -1,537.6 |
Total equity | 338.3 | 12,093.4 |
Goodwill and intangibles | 0 | 10,500.3 |
Working capital | 10.3 | 1,356.5 |
Loan receivable (Hongtai Sheng) | 258.7 | 472.4 |
Contract liabilities | 311.5 | 169.2 |
Cash Flow
| Metric (AUD K) | FY2024 | FY2025 |
|---|---|---|
Operating cash flow | -1,842.5 | -5,845.8 |
Capex | 0 | -76.5 |
Free cash flow | -1,842.5 | -5,922.3 |
Equity raised (net) | 2,482.7 | 7,471.8 |
Loans advanced (Hongtai Sheng) | -258.7 | -213.7 |
Dividends paid | 0 | 0 |
Buybacks | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2024 | FY2025 |
|---|---|---|
ROE (%) | — | -122.3 |
ROA (%) | — | -102.2 |
Current ratio (x) | 1.01 | 1.98 |
Debt/equity (x) | 0.37 | 0.02 |
Asset turnover (x) | — | 0.04 |
Region revenue (AUD K)
| Region revenue (AUD K) | FY2024 | FY2025 |
|---|---|---|
Asia | 6.9 | 297.6 |
North America | 0 | 0 |
Australia | 0 | 0 |
Total | 6.9 | 297.6 |
Region non-current assets (AUD K)
| Region non-current assets (AUD K) | FY2024 | FY2025 |
|---|---|---|
Asia | 328.0 | 10,670.2 |
Australia | 0 | 138.6 |
North America | 0 | 0 |
Per-Share Data
| Metric | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
Year-end share price (AUD cents) | 5.2 | 6.5 | 3.2 | 0.9 | 2.3 | 3.4 | 8.4 |
Share Price & Returns
| Window | Reference price | Change (calculated) |
|---|---|---|
YTD 2026 (vs 31 Dec 2025) | 8.4c | -31% |
~3-year (vs 31 Dec 2023) | 2.3c | +152% |
~5-year (vs 31 Dec 2021) | 3.2c | +81% |
Since IPO (Nov 2018) | 20.0c | -71% |
Valuation Snapshot
| Multiple | Value | Basis |
|---|---|---|
Market cap | ~A$63.1M | A$0.058 × ~1.087bn shares (StockWire X shows A$58.7M on 22 Sep 2026) |
Enterprise value | ~A$58.7M | Market cap minus A$5.14M cash plus A$0.72M debt and leases (30 Jun 2026; cash has since fallen) |
EV/Sales (TTM revenue A$23.4K) | ~2,500x | TTM = FY2025 − H1 FY2025 + H1 FY2026 |
P/B | ~4.1x | Equity A$15.52M |
P/tangible book | ~12.6x | Tangible equity ~A$5.0M |
Analyst Conclusions
Management guidance
No quantitative guidance is given. Qualitative priorities:
-
Publish measured 16nm power and performance data.
-
Supply engineering samples and evaluation boards to selected customers.
-
Start the 22nm full-mask tape-out in H2 2026.
-
Convert 22nm evaluations into design-ins.
-
Commercialise the ALICE and METRON drone platforms.
-
Deliver the India EyeFly3D pilot by Q4 2026.
-
Progress Nanoshield CSP licensing.
Consensus growth expectations
None. There is no broker coverage.
Bull case
-
Silicon is real, at two nodes. Few ASX microcaps have taken two designs through TSMC. Strong 16nm characterisation data, especially if it independently confirms the claimed efficiency lead, could open tier-one design-ins and justify a re-rating toward peers that already earn chip revenue.
-
Funding overhang is self-correcting near the current price. About 162M in-the-money options (A$0.045–A$0.05, expiring Dec 2026 to May 2027) could bring in about A$7.8M if exercised. That would roughly double the 30 June 2026 cash with no new placement discount.
-
Drone and defence optionality. Measured 48.5% cruise-efficiency gains, owned airframes and GPS-free swarm IP fit current defence-drone procurement themes. These are higher-value, faster-procurement niches than consumer wearables.
Bear case
-
Revenue is going backwards. Revenue was A$7K in H1 FY2026, and FY2025's A$298K came from one-off EyeFly3D shipments. Eighteen months after the EMASS deal, no chip revenue has been booked, while burn has doubled to about A$7.9M a year.
-
Dilution is structural. There are about 1.49bn fully diluted shares. Runway was about 7–8 months at 30 June 2026. The strategy now spans four verticals. Further equity raisings are likely, and each one dilutes per-share value before commercial proof arrives.
-
Governance and disclosure quality are below institutional standard. One independent director, an executive chair, no remuneration committee, an auditor change, repeated internal inconsistencies in the filings, an unsecured interest-free loan to a third party, and a large university donation together raise the cost of capital.
Key catalysts and monitorables (next 12 months)
-
Published 16nm silicon characterisation data: power per inference, wake latency and BLE RF performance.
-
First announced design-win or binding production purchase order for ECS-DoT. A$1M of cumulative revenue triggers the EMASS Class C rights.
-
Start and completion of the 22nm full-mask tape-out.
-
Sept-quarter 2026 Appendix 4C (late Oct 2026): cash balance and burn.
-
Exercise of the 93.4M A$0.05 options before 31 Dec 2026.
-
Repayment status of the Hongtai Sheng loan.
-
India EyeFly3D shipment by Q4 2026 and follow-on orders toward the 1M-unit exclusivity threshold.
-
First Drone Division revenue or defence engagements; NTU licence conversion decision.
-
FY2026 impairment test of the A$10.5M EMASS intangible (Feb 2027 accounts, Stantons' first full-year audit).
-
Board refresh to add independent directors.
Analyst verdict
Nanoveu is now a different company from the one that listed in 2018. The EyeFly3D and Nanoshield businesses, which never produced more than about A$0.8M in a year, have become secondary. The company is now an edge-AI fabless chip developer that is also building a drone business. The technical progress since the March 2025 EMASS acquisition is real and, for a company of this size, unusually fast. It took the 16nm design from architecture to GDS sign-off in about six months, completed a TSMC tape-out in January 2026, and received engineering samples in September 2026. Live drone trials showed a 48.5% average cruise-efficiency gain at under 10mW, and the company has signed reference-design collaborations with Bosch Sensortec, Semtech and Arrow. These are meaningful signals that the architecture works.
The financial picture is the reverse. Revenue fell 98% to A$7K in H1 FY2026. Operating burn doubled to A$3.9M per half. Cash of A$5.1M at 30 June 2026 implies a funding event or large option exercises by early 2027. About 59% of the balance sheet is an acquired intangible valued at the share price paid for it. Governance (one independent director out of five, an executive chair, no remuneration committee) and recurring inconsistencies in the filings fall short of what generalist institutions expect.
At roughly A$60M market capitalisation, the market is valuing ECS-DoT optionality and assigning little value to the legacy divisions. That price is reasonable only if the 16nm characterisation confirms a clear power-efficiency lead and leads to a disclosed design-win within the next two to three quarters. Without a design-win, the company returns to repeated placements at discounts. The stock is speculative and binary, so position size should be set accordingly. The next three checkpoints are the published 16nm silicon data, any binding production order, and the cash balance in the Sept-quarter and Dec-quarter 2026 Appendix 4Cs.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Appointed | Background / education | Independent? |
|---|---|---|---|---|
Dr David Pevcic | Executive Chairman | Director 3 Feb 2023; Executive Chair Oct 2024 | Investor in resources and technology. Chairs Infini Resources (ASX: I88) and Battery Age Minerals (ASX: BM8). BSc, MBBS, University of Western Australia. | No (executive) |
Alfred Chong | Managing Director and CEO; Founder | 14 Feb 2018 | Former Asia-Pacific CEO of Atex Media Command; CEO of THISS Technologies and 121View; CMO of 3D International. BSc Computer Science and MBA, University of San Francisco. | No (executive) |
Steven Apedaile | Non-Executive Director | 14 May 2018 | 30+ years in accounting (KPMG Hong Kong, Horwath Hong Kong). Executive Chairman of Sprintex (ASX: SIX). FCA, MAICD. | Yes |
Prof. Mohamed M. Sabry Aly | Non-Executive Director; EMASS Founder and CTO | 1 Dec 2025 | Founded EMASS while an Associate Professor at NTU. Former Stanford postdoctoral researcher. Task Force Lead for Singapore EDB's Future of Microelectronics initiative. More than 100 publications; part of DARPA's 3DSoC program. PhD. | No (founder, ~9.5% holder) |
Siyuan (Raymond) Chen | Executive Director and CFO | CFO 4 Feb 2025; Director 1 Dec 2025 | Previously at Iluka Resources, NRW Holdings and Equinox Resources; began at KPMG audit. MBA, Cambridge Judge. Engaged through Oxbridge Advisory Pty Ltd. | No (executive) |
Executive Leadership Team
| Name | Role | Appointed | Background |
|---|---|---|---|
Mark Goranson | CEO, Semiconductor Technologies division (EMASS) | Jan 2025 | 40+ years in semiconductors; senior roles at Intel, ON Semiconductor and TE Connectivity |
Dr Chee How Tan | Head of Drone Division | 2 Jul 2026 | Co-founder of Spinoff Robotics; 4+ years as a research fellow at SUTD in lean sensing and embodied perception for aerial robotics |
Harry Spindler | Company Secretary | 4 Feb 2025 | 23 years in governance and capital markets; CA ANZ, FINSIA |
Directors' Remuneration
| Name | Salary and fees | Non-monetary | Super/CPF | Share-based | Total | Performance-related (%) |
|---|---|---|---|---|---|---|
Alfred Chong | 293,158 | 9,478 | 12,951 | 105,561 | 421,148 | 25 |
Dr David Pevcic | 122,883 | 5,801 | 0 | 842,340 | 971,024 | 87 |
Raymond Chen | 114,000 | 242 | 0 | 0 | 114,242 | 0 |
Steven Apedaile | 56,220 | 5,801 | 0 | 4,057 | 66,078 | 6 |
Dr Michael Winlo (to 1 Dec 2025) | 36,308 | 5,318 | 5,160 | 32,610 | 79,396 | 41 |
Prof. Mohamed Sabry Aly (from 1 Dec 2025) | 27,748 | 242 | 0 | 3,689 | 31,679 | 12 |
Total KMP | 650,317 | 26,882 | 18,111 | 988,257 | 1,683,567 | 59 |
KMP remuneration total (AUD K) | FY2024 | FY2025 | — | — | — | — |
Total KMP remuneration | 616.7 | 1,683.6 | — | — | — | — |
Of which share-based payments | 151.2 | 988.3 | — | — | — | — |
Major Shareholders
| Holder | Shares | Approx. % of ~1.087bn | Additional securities | Source |
|---|---|---|---|---|
Prof. Mohamed Sabry Aly | 102,936,352 | 9.5 | 49,752,570 EMASS performance rights plus 5,000,000 VWAP rights | FY2025 Annual Report |
Dr David Pevcic (direct and indirect) | ~59,355,337 | 5.5 | 17,990,075 options; 5,000,000 rights | Annual Report plus Appendix 3Y (26 Jun 2026) |
Alfred Chong | 48,416,020 | 4.5 | 5,700,000 rights | Annual Report |
Steven Apedaile | 4,540,350 | 0.4 | 5,030,000 rights | Annual Report |
Raymond Chen | ~402,982 | 0.04 | 80,645 options plus placement options | Annual Report plus Appendix 3Y |
Board total | ~215.7M | ~19.8 | — | Calculated |
Governance Detail
| Security | Number |
|---|---|
Options | 270,576,171 |
Performance rights (at 30 Jun 2026) | 125,833,333 |
Spinoff performance rights | 4,000,000 |
ESIP performance rights (Jul 2026) | 6,000,000 |
Approximate fully diluted share count | ~1.49bn |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | Type | Notes |
|---|---|---|---|
Ultra-low-power edge-AI SoC | Ambiq Micro (NYSE: AMBQ) | Public, US | Apollo/Atomic families; FY2025 net sales US$72.5M; management sees a path to more than US$100M |
Ultra-low-power edge-AI SoC / IP | BrainChip (ASX: BRN) | Public, ASX | Akida neuromorphic IP and AKD1500 silicon; FY2025 revenue US$1.89M; net loss US$20.47M |
Edge-AI MCU / NPU | STMicroelectronics (STM32N6 and others) | Public, large-cap | Also a partner (sensing) |
Edge-AI MCU | Analog Devices (MAX78000 family) | Public, large-cap | CNN accelerator MCU |
Edge-AI MCU | NXP Semiconductors | Public, large-cap | i.MX RT / MCX with NPU |
Edge-AI MCU | Infineon | Public, large-cap | PSoC Edge |
Always-on audio AI | Syntiant | Private | Neural decision processors |
Ultra-low-power processors | GreenWaves Technologies | Private | GAP RISC-V processors |
Neuromorphic | Innatera | Private | Spiking neural processors |
Edge-AI silicon (higher power) | Hailo | Private | Vision accelerators |
Glasses-free 3D | Leia Inc.; Dimenco | Private | Lightfield / 3D display tech |
Tethered drones | Elistair; Hoverfly | Private | Tethered UAS for persistent surveillance |
Solar anti-soiling coatings | Various nanocoating vendors | Mixed | Fragmented |
Peer Comparison FY2025
| Metric | Nanoveu (FY2025, AUD) | Ambiq (FY2025, USD) | BrainChip (FY2025, USD) |
|---|---|---|---|
Revenue | A$0.30M | US$72.5M | US$1.89M |
Revenue growth | +4,230% (from A$6.9K) | — | +374% |
Gross margin | -212% | Q1 FY2026 non-GAAP guidance 44–45% | — |
Net margin | -2,554% | — | About -1,083% (calculated) |
R&D intensity | Research costs 256% of revenue (understated) | Q4 FY2025 non-GAAP R&D US$9.3M (~45% of Q4 sales) | — |
Recent Developments
--



